Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.

Journal: Cancer Discovery
Published:
Authors
Sriram Venneti, Abed Kawakibi, Sunjong Ji, Sebastian Waszak, Stefan Sweha, Mateus Mota, Matthew Pun, Akash Deogharkar, Chan Chung, Rohinton Tarapore, Samuel Ramage, Andrew Chi, Patrick Wen, Isabel Arrillaga Romany, Tracy Batchelor, Nicholas Butowski, Ashley Sumrall, Nicole Shonka, Rebecca Harrison, John De Groot, Minesh Mehta, Matthew Hall, Doured Daghistani, Timothy Cloughesy, Benjamin Ellingson, Kevin Beccaria, Pascale Varlet, Michelle Kim, Yoshie Umemura, Hugh Garton, Andrea Franson, Jonathan Schwartz, Rajan Jain, Maureen Kachman, Heidi Baum, Charles Burant, Sophie Mottl, Rodrigo Cartaxo, Vishal John, Dana Messinger, Tingting Qin, Erik Peterson, Peter Sajjakulnukit, Karthik Ravi, Alyssa Waugh, Dustin Walling, Yujie Ding, Ziyun Xia, Anna Schwendeman, Debra Hawes, Fusheng Yang, Alexander Judkins, Daniel Wahl, Costas Lyssiotis, Daniel De Nava, Marta Alonso, Augustine Eze, Jasper Spitzer, Susanne Schmidt, Ryan Duchatel, Matthew Dun, Jason Cain, Li Jiang, Sylwia Stopka, Gerard Baquer, Michael Regan, Mariella Filbin, Nathalie Y Agar, Lili Zhao, Chandan Kumar Sinha, Rajen Mody, Arul Chinnaiyan, Ryo Kurokawa, Drew Pratt, Viveka Yadav, Jacques Grill, Cassie Kline, Sabine Mueller, Adam Resnick, Javad Nazarian, Joshua Allen, Yazmin Odia, Sharon Gardner, Carl Koschmann
Relevant Conditions

Gliomatosis Cerebri, Glioma